News

Risk for all-cause, CVD, cancer mortality lower with healthiest lifestyle for those with type 2 diabetes

Guidelines address lifestyle recommendations, individualized BP targets, SGLT2 inhibitor, GLP1-RA tx

Tracking basal body temperature and other parameters improves accuracy of ovulation detection

Reduction seen in primary end point and seven prespecified secondary outcomes, including mortality

Incidence of ischemic cardiovascular events lower but major bleeding increased versus placebo plus aspirin

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for August 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Cerebrovascular Risk …

Most cerebrovascular risk factors linked to higher risk for subsequent diagnosis of Parkinson disease

Risks for pancreatitis, pancreatic cancer higher in Korean patients with newly diagnosed T2DM

Review indicates little to no effect on newly diagnosed diabetes, measures of glucose metabolism

From 2010 to 2017, no significant change seen in age-adjusted mortality rates for stroke, diabetes